Publication: 4433

Publication: 4433

Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202).

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 43 (29) 3170-83

Year:: 2025
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 15

Parents:: 3069 3137 3433
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:: Health Outcomes

Pharmas:: Novartis
Grants:: U10CA180821, U10CA180882, UG1CA189823, UG1CA233180, UG1CA233253, UG1CA233290, UG1CA233320; U10CA180863 and CCS 707213 (CCTG); and U10CA180888 (SWOG)

Corr. Author:
Authors:: Emily K Bergsland Susan Geyer Timothy R Asmis Spencer C Behr J Philip Kuebler Priya Kumthekar Gina Mazza Michael L Maitland Donna Niedzwiecki Andrew B Nixon Lawrence Howard Schwartz Jonathan R Strosberg Alan P Venook Eileen M O'Reilly Jeffrey A Meyerhardt

Networks:: CA824, COLUMBUS, FL065, LAPS-IL036, LAPS-MA036, LAPS-NC010, LAPS-NY016, VA002

Study: Alliance-A021202
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: